Irinotecan or oxaliplatin for first-line treatment of advanced colorectal cancer?
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/16/6/845/484393/mdi196.pdf
Reference12 articles.
1. Oxaliplatin plus high-dose folinic acid and 5-fluorouracil i.v. bolus (OXAFAFU) versus irinotecan plus high-dose folinic acid and 5-fluorouracil i.v. bolus (IRIFAFU) in patients with metastatic colorectal carcinoma: a Southern Italy Cooperative Oncology Group phase III trial
2. Irinotecan or oxaliplatin combined with leucovorin and 5-fluorouracil as first-line treatment in advanced colorectal cancer: a multicenter randomized phase 2 study;Kalafonos;Ann Oncol,2005
3. randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer;Goldberg;J Clin Oncol,2004
4. New options and old dilemmas in the treatment of patients with advanced colorectal cancer;Punt;Ann Oncol,2004
5. André T, Achille E et al. FOLFIRI followed by FOLFOX6 or the reversed sequence in advanced colorectal cancer: a randomized GERCOR study;Tournigand;J Clin Oncol,2004
Cited by 17 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Systemic Treatment: Maintenance Compared with Holiday;American Society of Clinical Oncology Educational Book;2015-05
2. Optimal duration of systemic treatment in metastatic colorectal cancer;Current Opinion in Oncology;2014-07
3. Role of cetuximab in first-line treatment of metastatic colorectal cancer;World Journal of Gastroenterology;2014
4. Impact of biomarkers on clinical trial risk;Pharmacogenomics;2013-10
5. Defining resectability of colorectal liver metastases: how and why?;Colorectal Cancer;2013-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3